GBM in the <br><span>national spotlight</span>

GBM in the
national spotlight

When high-profile people are diagnosed with this rare, yet aggressive disease, many patients feel empathy and hope for more progress.

Learn More
leaning on family<br><span> for support</span>

leaning on family
for support

Debbie Letniak, who has glioblastoma, finds strength in the support from her close-knit family.

Learn More
more than ‘thinking<br><span>outside of the box’</span>

more than ‘thinking
outside of the box’

Our General Manager Germany, Tobias Weizel, said he feels lucky to be a part of Novocure’s mission of bringing a profoundly different cancer treatment to patients worldwide.

Learn More
a decade of working<br><span> for Novocure</span>

a decade of working
for Novocure

Sharyn Ruperti, Clinical Trial Manager, discusses her lengthy career at Novocure. Read about her views on the evolution of the company and what sets us apart.

Learn More
the science <br><span>of research</span>

the science
of research

Our Director of Science, Ze’ev Bomzon, discusses his research on Tumor Treating Fields and the importance of effectively explaining the technology.

Learn More

the story
of Novocure

In 2000, our founder Professor Yoram Palti sought to leverage his expertise in biophysics to develop a new way to treat cancer that would destroy tumor cells while sparing healthy tissue and avoiding many of the life-altering side effects of existing cancer therapies. Novocure has grown into an international oncology company with more than 450 employees and operations in the U.S., Europe and Asia.

Learn More

Tumor Treating Fields, or TTFields, are low intensity, alternating electric fields.

TTFields disrupt cancer cell division through physical interactions with key molecules during mitosis. Our non-invasive treatment targets solid tumors.


explore our clinical pipeline.

Our research shows that TTFields have an antimitotic effect in more than 15 solid tumor types in culture and in eight in vivo tumor models.


we are dedicated to improving the lives of cancer patients.

Patients remain at the heart of the work we do every day. Learn more about our patients, their families and the people working to deliver patient-forward therapies to treat cancer.